Listed by the USPTO as SOROUSH, LAYLA
Tech Center 2800 • Art Units: 1617 1622 1625 1627 2834
This examiner grants 40% of resolved cases
SOROUSH, LAYLA is assigned to tech center 2800 and art unit 1617. The record shows 891 resolved cases, an allowance rate of 40.5%, and a median of 1379 days to allowance. The allowance rate identifies a challenging prosecution profile, while the timing figure indicates that applications may require extended attention before reaching allowance.
Interviews are associated with a 43.4% lift in allowance rate, making interview preparation a central consideration for practitioners working with this examiner. Arcutis Biotherapeutics Inc., Xenon Pharmaceuticals Inc., and Mayo Foundation for Medical Education and Research are the leading companies. The listed firms are ROTHWELL, FIGG, ERNST & MANBECK, P.C., OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P., and SUGHRUE MION, PLLC.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18861037 | TOBACCO ALKALOID INSECT REPELLENT IN PLANTS | Non-Final OA | Philip Morris Products S.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy40.5% of resolved applications examined by Layla Soroush were allowed (891 resolved cases), compared with 34.1% across Art Unit 1617 over the last five years.
This examiner's interview lift is +43.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Layla Soroush took 1,379 days on average from filing to allowance.
Layla Soroush examines applications in Art Unit 1617 in Tech Center 2800 (Semiconductors, Circuits & Optics).
